References
- HatfieldIAllisonAFlightLJuliousSADimairoMAdaptive designs undertaken in clinical research: a review of registered clinical trialsTrials201617115026993469
- MistryPDunnJAMarshallAA literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelinesBMC Med Res Methodol201717110828720094
- United States Food and Drug AdministrationAdaptive Designs for Medical Device Clinical Studies Guidance for Industry and Food and Drug Administration StaffUnited States Department of Health and Human Services2016
- European Medicines Agency Committee for Medicinal Products for Human Use (CHMP)Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis planEuropean Medicines Agency2006
- MeurerWJLegockiLMawochaSAttitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) projectTrials20161737327473126
- BartlettRHRoloffDWCornellRGAndrewsAFDillonPWZwischenbergerJBExtracorporeal circulation in neonatal respiratory failure: a prospective randomized studyPediatrics19857644794873900904
- SavilleBRConnorJTAyersGDAlvarezJThe utility of Bayesian predictive probabilities for interim monitoring of clinical trialsClin Trials201411448549324872363
- BauerPBretzFDragalinVKonigFWassmerGTwenty-five years of confirmatory adaptive designs: opportunities and pitfallsStat Med201635332534725778935
- KramsMLeesKRHackeWGrieveAPOrgogozoJMFordGAASTIN Study InvestigatorsAcute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic strokeStroke200334112543254814563972
- GrieveAPKramsMASTIN: a Bayesian adaptive dose-response trial in acute strokeClin Trials20052434035116281432
- BauerPKoenigFThe reassessment of trial perspectives from interim data-a critical viewStat Med2006251233616220517
- CasaliPGLe CesneAPoveda VelascoATime to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group intergroup randomized trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasJ Clin Oncol201533364276428326573069
- BolstadWMCurranJMIntroduction to Bayesian StatisticsJohn Wiley & Sons, IncHoboken, New Jersey2016
- CuffeRLLawrenceDStoneAVandemeulebroeckeMWhen is a seamless study desirable? Case studies from different pharmaceutical sponsorsPharm Stat201413422923724891148
- JouraEAGiulianoARIversenOEBroad Spectrum HPV Vaccine StudyA 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenN Engl J Med2015372871172325693011
- ChenYHGesserRLuxembourgAA seamless phase IIB/III adaptive outcome trial: design rationale and implementation challengesClin Trials2015121849025278227
- SimonNSimonRAdaptive enrichment designs for clinical trialsBiostatistics201314461362523525452
- AntoniouMJorgensenALKolamunnage-DonaRBiomarker-guided adaptive trial designs in Phase II and Phase III: a methodological reviewPLoS One2016112e014980326910238
- ParkJWLiuMCYeeDAdaptive randomization of neratinib in early breast cancerN Engl J Med20163751112227406346
- RugoHSOlopadeOIDeMicheleAAdaptive randomization of veliparib-carboplatin treatment in breast cancerN Engl J Med20163751233427406347
- KimESHerbstRSWistubaIIThe BATTLE trial: personalizing therapy for lung cancerCancer Discov201111445322586319
- RosenblumMHanleyDFAdaptive enrichment designs for stroke clinical trialsStroke20174872021202528536178
- MorganTZuccarelloMNarayanRKeylPLaneKHanleyDPreliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trialActa Neurochir Suppl200810514715119066101
- HanleyDFThompsonREMuschelliJSafety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialLancet Neurol201615121228123727751554
- LegockiLJMeurerWJFrederiksenSClinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysisBMC Med Ethics2015162725933921